In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.
The closing price of Cognition Therapeutics Inc (NASDAQ: CGTX) was $1.35 for the day, up 0.75% from the previous closing price of $1.34. In other words, the price has increased by $0.75 from its previous closing price. On the day, 1.25 million shares were traded. CGTX stock price reached its highest trading level at $1.42 during the session, while it also had its lowest trading level at $1.33.
Ratios:
Our analysis of CGTX’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 1.54 and its Current Ratio is at 1.54. In the meantime, Its Debt-to-Equity ratio is 0.07 whereas as Long-Term Debt/Eq ratio is at 0.03.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of. The stock’s future direction. In the most recent recommendation for the company, B. Riley Securities on December 19, 2024, Upgraded its rating to Buy and sets its target price to $1.50 from $1 previously.
On November 03, 2021, Oppenheimer started tracking the stock assigning a Outperform rating and target price of $22.Oppenheimer initiated its Outperform rating on November 03, 2021, with a $22 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Jan 31 ’25 when Ricciardi Lisa bought 38,851 shares for $0.77 per share. The transaction valued at 30,001 led to the insider holds 38,851 shares of the business.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CGTX now has a Market Capitalization of 119102240 and an Enterprise Value of 88912472.
Stock Price History:
The Beta on a monthly basis for CGTX is 1.22, which has changed by 2.292683 over the last 52 weeks, in comparison to a change of 0.15535986 over the same period for the S&P500. Over the past 52 weeks, CGTX has reached a high of $3.83, while it has fallen to a 52-week low of $0.22. The 50-Day Moving Average of the stock is -12.01%, while the 200-Day Moving Average is calculated to be 82.03%.
Shares Statistics:
CGTX traded an average of 11.28M shares per day over the past three months and 4250090 shares per day over the past ten days. A total of 88.22M shares are outstanding, with a floating share count of 70.90M. Insiders hold about 19.63% of the company’s shares, while institutions hold 5.95% stake in the company. Shares short for CGTX as of 1756425600 were 9205855 with a Short Ratio of 0.82, compared to 1753920000 on 5319846. Therefore, it implies a Short% of Shares Outstanding of 9205855 and a Short% of Float of 11.2399995.
Earnings Estimates
The market rating for Cognition Therapeutics Inc (CGTX) is a result of the insights provided by 4.0 analysts actively involved in the assessment.The consensus estimate for the next quarter is -$0.08, with high estimates of -$0.05 and low estimates of -$0.13.
Analysts are recommending an EPS of between -$0.33 and -$0.51 for the fiscal current year, implying an average EPS of -$0.4. EPS for the following year is -$0.28, with 3.0 analysts recommending between -$0.15 and -$0.37.
